|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.962
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.799
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.776
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.749
|
|
|
|
cholesterol homeostasis
|
GO:0042632 |
44 |
0.677
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.666
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.597
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.576
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.553
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.526
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.463
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.458
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.457
|
Rat |
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.418
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.416
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
58 |
0.389
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.385
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.354
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.342
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.318
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.306
|
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.305
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.286
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.270
|
|
|
|
activation of nf kappab inducing kinase activity
|
GO:0007250 |
4 |
0.253
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
59 |
0.247
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.242
|
|
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.238
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.235
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.230
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.225
|
|
|
|
positive regulation of camp mediated signaling
|
GO:0043950 |
3 |
0.221
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.210
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.202
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.202
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.201
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.200
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.195
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.194
|
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.191
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.190
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.190
|
Rat |
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.190
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.187
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.182
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.176
|
|
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
28 |
0.176
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.176
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.171
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.171
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.167
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.163
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.162
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.162
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.159
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.156
|
Rat |
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.155
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.155
|
|
|
|
regulation of sterol transport
|
GO:0032371 |
17 |
0.154
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.154
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.154
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.152
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.151
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.151
|
Human |
|
|
gland development
|
GO:0048732 |
330 |
0.144
|
Mouse |
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.143
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.140
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.140
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.139
|
|
|
|
keratinocyte proliferation
|
GO:0043616 |
21 |
0.136
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.133
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.130
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.129
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.129
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.129
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.129
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.128
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.127
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.126
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.126
|
|
|
|
glucan metabolic process
|
GO:0044042 |
32 |
0.123
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.122
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.121
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.119
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.118
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.116
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.116
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.115
|
|
|
|
positive regulation of inositol phosphate biosynthetic process
|
GO:0060732 |
2 |
0.114
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.114
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.114
|
|
|
|
phosphatidylinositol mediated signaling
|
GO:0048015 |
41 |
0.114
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.113
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.110
|
|
|
|
regulation of glucose metabolic process
|
GO:0010906 |
60 |
0.108
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.108
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.107
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.106
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
40 |
0.105
|
Human |
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.104
|
|
|
|
circadian regulation of gene expression
|
GO:0032922 |
48 |
0.104
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.104
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.104
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.104
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.104
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.104
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.104
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.103
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.103
|
|
|
|
sterol metabolic process
|
GO:0016125 |
58 |
0.103
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.102
|
Mouse |
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.102
|
Human |
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.102
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.102
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.102
|
Rat |
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.102
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.100
|
|
|
|
regulation of fatty acid biosynthetic process
|
GO:0042304 |
12 |
0.100
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.099
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.099
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.098
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.098
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.097
|
|
|
|
retinoid metabolic process
|
GO:0001523 |
24 |
0.097
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.096
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.095
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.095
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.095
|
|
|
|
regulation of systemic arterial blood pressure by hormone
|
GO:0001990 |
25 |
0.095
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.093
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.093
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.092
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.091
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.091
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.091
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.089
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.089
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.089
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.089
|
|
|
|
regulation of antimicrobial humoral response
|
GO:0002759 |
3 |
0.088
|
|
|
|
regulation of carbohydrate biosynthetic process
|
GO:0043255 |
40 |
0.088
|
|
|
|
cholesterol transport
|
GO:0030301 |
38 |
0.087
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.087
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.087
|
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.086
|
|
|
|
negative regulation of sterol transport
|
GO:0032372 |
4 |
0.086
|
|
|
|
ventricular cardiac muscle tissue morphogenesis
|
GO:0055010 |
32 |
0.085
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.085
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.085
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.084
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.084
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.084
|
|
|
|
toll like receptor signaling pathway
|
GO:0002224 |
38 |
0.083
|
|
|
|
cholesterol efflux
|
GO:0033344 |
24 |
0.083
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.083
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.082
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.081
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.080
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.080
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.080
|
Mouse |
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.079
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.079
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.079
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.079
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.079
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.079
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.078
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.078
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.078
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.077
|
|
|
|
regulation of lipid transport
|
GO:0032368 |
36 |
0.077
|
|
|
|
positive regulation of fatty acid metabolic process
|
GO:0045923 |
8 |
0.077
|
|
|
|
regulation of steroid metabolic process
|
GO:0019218 |
39 |
0.076
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.076
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.073
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.073
|
|
|
|
vitamin d biosynthetic process
|
GO:0042368 |
3 |
0.072
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.072
|
|
|
|
cell differentiation involved in embryonic placenta development
|
GO:0060706 |
26 |
0.071
|
|
|
|
intestinal absorption
|
GO:0050892 |
13 |
0.071
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.070
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.070
|
|
|
|
positive regulation of insulin receptor signaling pathway
|
GO:0046628 |
4 |
0.070
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.070
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.070
|
|
|
|
polysaccharide metabolic process
|
GO:0005976 |
39 |
0.069
|
|
|
|
negative regulation of cholesterol transport
|
GO:0032375 |
4 |
0.069
|
|
|
|
regulation of plasminogen activation
|
GO:0010755 |
4 |
0.069
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.068
|
|
|
|
fibrinolysis
|
GO:0042730 |
3 |
0.068
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.068
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.067
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.067
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.067
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.066
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.066
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.066
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.066
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.065
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.064
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.064
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.064
|
Mouse |
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.064
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.064
|
|
|
|
cellular glucan metabolic process
|
GO:0006073 |
32 |
0.064
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.063
|
|
|
|
regulation of nitrogen cycle metabolic process
|
GO:1903314 |
1 |
0.063
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.062
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.062
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.062
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.061
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.061
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.061
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.061
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.060
|
|
|
|
negative regulation of protein transport
|
GO:0051224 |
46 |
0.060
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.060
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.060
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.059
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.058
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.058
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.058
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.058
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.058
|
|
|
|
regulation of antimicrobial peptide biosynthetic process
|
GO:0002805 |
1 |
0.058
|
|
|
|
regulation of jak stat cascade
|
GO:0046425 |
34 |
0.058
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.057
|
|
|
|
glutamate metabolic process
|
GO:0006536 |
9 |
0.056
|
|
|
|
regulation of cholesterol transport
|
GO:0032374 |
17 |
0.056
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.056
|
|
|
|
positive regulation of fatty acid biosynthetic process
|
GO:0045723 |
3 |
0.056
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.056
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.056
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.056
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.056
|
|
|
|
sterol transport
|
GO:0015918 |
38 |
0.055
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.055
|
|
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.055
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.055
|
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.055
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.055
|
|
|
|
lipoprotein metabolic process
|
GO:0042157 |
43 |
0.054
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.054
|
|
|
|
cholesterol metabolic process
|
GO:0008203 |
56 |
0.054
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.054
|
|
|
|
neurological system process involved in regulation of systemic arterial blood pressure
|
GO:0001976 |
18 |
0.054
|
|
|
|
regulation of phosphatidylinositol 3 kinase signaling
|
GO:0014066 |
30 |
0.054
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.053
|
|
|
|
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development
|
GO:0060528 |
4 |
0.053
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.053
|
|
|
|
antimicrobial peptide biosynthetic process
|
GO:0002777 |
2 |
0.053
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.053
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.053
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.053
|
|
|
|
hormone mediated signaling pathway
|
GO:0009755 |
23 |
0.053
|
|
|
|
acylglycerol homeostasis
|
GO:0055090 |
16 |
0.052
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.052
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.051
|
|
|
|
zymogen activation
|
GO:0031638 |
41 |
0.051
|
|
|
|
antimicrobial peptide production
|
GO:0002775 |
2 |
0.051
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.051
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.051
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.051
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.051
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.050
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.050
|
|
|
|
inositol lipid mediated signaling
|
GO:0048017 |
41 |
0.050
|
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.050
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.050
|
|
|
|
peptide metabolic process
|
GO:0006518 |
46 |
0.050
|
|
|
|
ventricular cardiac muscle cell action potential
|
GO:0086005 |
4 |
0.050
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.050
|
|
|
|
negative regulation of neuron projection regeneration
|
GO:0070571 |
3 |
0.050
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.050
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.049
|
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
58 |
0.049
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.049
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.049
|
Rat |
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.049
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.049
|
|
|
|
cellular polysaccharide metabolic process
|
GO:0044264 |
38 |
0.049
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.049
|
|
|
|
regulation of systemic arterial blood pressure by renin angiotensin
|
GO:0003081 |
20 |
0.048
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.048
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.048
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
61 |
0.048
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.048
|
|
|
|
diterpenoid metabolic process
|
GO:0016101 |
24 |
0.048
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.048
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.048
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.047
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.047
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.047
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.047
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.047
|
Mouse |
|
|
digestion
|
GO:0007586 |
40 |
0.046
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.046
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.046
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.046
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.046
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.045
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
61 |
0.045
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.045
|
|
|
|
trophoblast giant cell differentiation
|
GO:0060707 |
15 |
0.045
|
|
|
|
pancreas development
|
GO:0031016 |
57 |
0.044
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.044
|
|
|
|
coenzyme metabolic process
|
GO:0006732 |
52 |
0.044
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.044
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.044
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.044
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.043
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.043
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.043
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.043
|
|
|
|
vasodilation
|
GO:0042311 |
28 |
0.043
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.042
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.042
|
|
|
|
regulation of vitamin metabolic process
|
GO:0030656 |
3 |
0.042
|
|
|
|
c21 steroid hormone biosynthetic process
|
GO:0006700 |
3 |
0.042
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.042
|
|
|
|
response to bile acid
|
GO:1903412 |
1 |
0.042
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.042
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.042
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.042
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.041
|
|
|
|
terpenoid metabolic process
|
GO:0006721 |
25 |
0.041
|
|
|
|
regulation of inositol trisphosphate biosynthetic process
|
GO:0032960 |
3 |
0.041
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.041
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.041
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.041
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.041
|
|
|
|
wnt signaling pathway involved in kidney development
|
GO:0061289 |
2 |
0.040
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.040
|
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
54 |
0.040
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.040
|
|
|
|
regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903555 |
50 |
0.040
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.040
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.040
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.040
|
|
|
|
positive regulation of cellular carbohydrate metabolic process
|
GO:0010676 |
29 |
0.040
|
|
|
|
regulation of blood volume by renin angiotensin
|
GO:0002016 |
7 |
0.040
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.039
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.039
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.039
|
|
|
|
dibenzo p dioxin metabolic process
|
GO:0018894 |
1 |
0.039
|
|
|
|
one carbon metabolic process
|
GO:0006730 |
1 |
0.039
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.039
|
|
|
|
regulation of calcidiol 1 monooxygenase activity
|
GO:0060558 |
1 |
0.038
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.038
|
|
|
|
peptide biosynthetic process
|
GO:0043043 |
11 |
0.038
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.038
|
|
|
|
regulation of ammonia assimilation cycle
|
GO:2001248 |
1 |
0.037
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.037
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.037
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.037
|
|
|
|
regulation of cyclic nucleotide metabolic process
|
GO:0030799 |
40 |
0.037
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.037
|
|
|
|
auditory receptor cell fate determination
|
GO:0042668 |
3 |
0.036
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.036
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.036
|
|
|
|
regulation of inositol phosphate biosynthetic process
|
GO:0010919 |
3 |
0.036
|
|
|
|
pattern recognition receptor signaling pathway
|
GO:0002221 |
47 |
0.036
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.036
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.036
|
|
|
|
positive regulation of fatty acid oxidation
|
GO:0046321 |
4 |
0.036
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.036
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.036
|
|
|
|
memory
|
GO:0007613 |
58 |
0.035
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.035
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.035
|
|
|
|
regulation of steroid biosynthetic process
|
GO:0050810 |
26 |
0.035
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.035
|
Rat |
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.035
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.035
|
Mouse |
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.035
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.034
|
|
|
|
regulation of glutamine family amino acid metabolic process
|
GO:0000820 |
1 |
0.034
|
|
|
|
cellular response to gonadotropin stimulus
|
GO:0071371 |
4 |
0.034
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.034
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.034
|
|
|
|
monocarboxylic acid transport
|
GO:0015718 |
44 |
0.034
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.034
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.034
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.034
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.034
|
Rat |
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.034
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.033
|
|
|
|
phosphatidylinositol 3 kinase signaling
|
GO:0014065 |
36 |
0.033
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.033
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.033
|
|
|
|
glycogen metabolic process
|
GO:0005977 |
32 |
0.033
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.033
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.033
|
|
|
|
organic acid catabolic process
|
GO:0016054 |
51 |
0.033
|
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
52 |
0.033
|
|
|
|
regulation of toll like receptor signaling pathway
|
GO:0034121 |
20 |
0.033
|
|
|
|
aortic valve morphogenesis
|
GO:0003180 |
4 |
0.032
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.032
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.032
|
|
|
|
atrial ventricular junction remodeling
|
GO:0003294 |
2 |
0.032
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.032
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.032
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.032
|
|
|
|
brain renin angiotensin system
|
GO:0002035 |
5 |
0.032
|
|
|
|
regulation of cytokine biosynthetic process
|
GO:0042035 |
59 |
0.032
|
|
|
|
tumor necrosis factor superfamily cytokine production
|
GO:0071706 |
51 |
0.031
|
|
|
|
innate immune response activating signal transduction
|
GO:0002758 |
50 |
0.031
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.031
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
44 |
0.031
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.031
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.031
|
|
|
|
ammonia assimilation cycle
|
GO:0019676 |
2 |
0.031
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.031
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.031
|
|
|
|
mechanoreceptor differentiation
|
GO:0042490 |
67 |
0.031
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.031
|
|
|
|
glutamine family amino acid metabolic process
|
GO:0009064 |
15 |
0.030
|
|
|
|
epithelial cell differentiation involved in prostate gland development
|
GO:0060742 |
13 |
0.030
|
|
|
|
activation of adenylate cyclase activity
|
GO:0007190 |
4 |
0.030
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.030
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.030
|
Rat |
|
|
glycosylation
|
GO:0070085 |
62 |
0.030
|
|
|
|
jak stat cascade
|
GO:0007259 |
42 |
0.030
|
|
|
|
positive regulation of cholesterol homeostasis
|
GO:2000189 |
2 |
0.030
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.030
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.030
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.030
|
Mouse |
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.029
|
|
|
|
tumor necrosis factor production
|
GO:0032640 |
50 |
0.029
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.029
|
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.029
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.029
|
|
|
|
activation of innate immune response
|
GO:0002218 |
56 |
0.029
|
|
|
|
milk ejection
|
GO:0060156 |
1 |
0.029
|
|
|
|
single fertilization
|
GO:0007338 |
82 |
0.029
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.028
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.028
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.028
|
|
|
|
regulation of antimicrobial peptide production
|
GO:0002784 |
1 |
0.028
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.028
|
|
|
|
cellular response to bile acid
|
GO:1903413 |
1 |
0.028
|
|
|
|
regulation of tumor necrosis factor production
|
GO:0032680 |
49 |
0.028
|
|
|
|
renin angiotensin regulation of aldosterone production
|
GO:0002018 |
3 |
0.028
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.028
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.028
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.028
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.028
|
Mouse |
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.027
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.027
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.027
|
Rat |
|
|
spinal cord oligodendrocyte cell differentiation
|
GO:0021529 |
3 |
0.027
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.027
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.027
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.027
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.027
|
|
|
|
regulation of purine nucleotide biosynthetic process
|
GO:1900371 |
34 |
0.027
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.027
|
|
|
|
cellular aldehyde metabolic process
|
GO:0006081 |
12 |
0.027
|
|
|
|
membrane depolarization
|
GO:0051899 |
64 |
0.027
|
|
|
|
regulation of tissue remodeling
|
GO:0034103 |
38 |
0.027
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.027
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.027
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.027
|
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.027
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.027
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.027
|
|
|
|
cellular biogenic amine metabolic process
|
GO:0006576 |
28 |
0.027
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.026
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.026
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.026
|
|
|
|
isoprenoid metabolic process
|
GO:0006720 |
29 |
0.026
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.026
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.026
|
|
|
|
directional locomotion
|
GO:0033058 |
3 |
0.026
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.026
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.026
|
|
|
|
water transport
|
GO:0006833 |
12 |
0.026
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
43 |
0.026
|
|
|
|
paraxial mesodermal cell fate commitment
|
GO:0048343 |
2 |
0.026
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.026
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.026
|
|
|
|
visceral serous pericardium development
|
GO:0061032 |
2 |
0.026
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.025
|
|
|
|
positive regulation of phosphatidylinositol 3 kinase signaling
|
GO:0014068 |
20 |
0.025
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.025
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.025
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.025
|
|
|
|
regulation of renal output by angiotensin
|
GO:0002019 |
2 |
0.025
|
|
|
|
positive regulation of nucleotide biosynthetic process
|
GO:0030810 |
26 |
0.025
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.025
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.025
|
|